| Gene ID | 217 |
| Symbol | ALDH2 |
| Synonymous | ALDH-E2|ALDHI|ALDM |
| Full name | aldehyde dehydrogenase 2 family (mitochondrial) |
| Gene description | ALDH class 2|acetaldehyde dehydrogenase 2|aldehyde dehydrogenase, mitochondrial|liver mitochondrial ALDH|nucleus-encoded mitochondrial aldehyde dehydrogenase 2 |
| Cytoband | 12q24.2 |
| Gene type | protein-coding |
| Synonymous | MIM:100650; HGNC:HGNC:404; Ensembl:ENSG00000111275; HPRD:00003; Vega:OTTHUMG00000169603 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Valine, leucine and isoleucine degradation;KEGG PATHWAY;hsa00280 |
Pathway | ethanol degradation IV (peroxisomal);BioCyc;PWY66-162 |
Pathway | tryptophan degradation X (mammalian, via tryptamine);BioCyc;PWY-6307 |
Pathway | Glycerolipid metabolism;KEGG PATHWAY;hsa00561 |
Pathway | Biological oxidations;Reactome;REACT:13433 |
Pathway | Tryptophan metabolism;KEGG PATHWAY;hsa00380 |
Pathway | serotonin degradation;BioCyc;PWY-6313 |
Pathway | ethanol degradation II (cytosol);BioCyc;PWY66-21 |
Pathway | Pyruvate metabolism;KEGG PATHWAY;hsa00620 |
Pathway | Propanoate metabolism;KEGG PATHWAY;hsa00640 |
Pathway | Glycolysis / Gluconeogenesis;KEGG PATHWAY;hsa00010 |
Pathway | Ascorbate and aldarate metabolism;KEGG PATHWAY;hsa00053 |
Pathway | noradrenaline and adrenaline degradation;BioCyc;PWY-6342 |
Pathway | Pentose and glucuronate interconversions;KEGG PATHWAY;hsa00040 |
Pathway | Ethanol oxidation;PID Reactome;500209 |
Pathway | Synaptic Transmission;Reactome;REACT:13685 |
Pathway | 5-Hydroxytryptamine degredation;PANTHER;P04372 |
Pathway | dopamine degradation;BioCyc;PWY6666-2 |
Pathway | Fatty acid metabolism;KEGG PATHWAY;hsa00071 |
Pathway | fatty acid alpha-oxidation;BioCyc;PWY-2501 |
Pathway | putrescine degradation III;BioCyc;PWY-0 |
Pathway | Lysine degradation;KEGG PATHWAY;hsa00310 |
Pathway | Metabolism of serotonin;PID Reactome;500159 |
Pathway | beta-alanine biosynthesis V;BioCyc;PWY-5760 |
Pathway | beta-Alanine metabolism;KEGG PATHWAY;hsa00410 |
Pathway | Arginine and proline metabolism;KEGG PATHWAY;hsa00330 |
Pathway | Metabolic pathways;KEGG PATHWAY;hsa01100 |
Pathway | oxidative ethanol degradation III (microsomal);BioCyc;PWY66-161 |
Pathway | Histidine metabolism;KEGG PATHWAY;hsa00340 |
Disease | cirrhosis, alcoholic;GAD |
Disease | Alcoholic liver disease;FunDO |
Disease | Sublingual nitroglycerin, susceptibility to poor response to;OMIM |
Disease | Lung cancer;FunDO |
Disease | liver disease, alcoholic;GAD |
Disease | Liver cancer;FunDO |
Disease | Alcohol sensitivity, acute;OMIM |
Disease | Adenoma;FunDO |
Disease | Pancreatitis;FunDO |
Disease | IMMUNE;GAD |
Disease | alcohol abuse;GAD |
Disease | Hangover, susceptibility to;OMIM |
Disease | pancreatitis;GAD |
Disease | head and neck cancer;GAD |
Disease | Esophageal cancer, alcohol-related, susceptibility to;OMIM |
Disease | Hypertension;FunDO |
Disease | alcoholism;GAD |
Disease | Colon cancer;FunDO |
Disease | Hematological and biochemical traits;NHGRI |
Disease | METABOLIC;GAD |
Disease | Drug abuse;FunDO |
Disease | bone density;GAD |
Disease | esophageal cancer;GAD |
Disease | CHEMDEPENDENCY;GAD |
Disease | Esophageal tumor;FunDO |
Disease | CARDIOVASCULAR;GAD |
Disease | multiple oesophageal dysplasia;GAD |
Disease | CANCER;GAD |
Disease | Liver Cirrhosis;GAD |
Disease | Pancreas disease;FunDO |
Disease | Kidney failure;FunDO |
Disease | medicamentosa-like dermatitis, trichloroethylene;GAD |
Disease | Conduct disorder;FunDO |
Disease | Squamous cell cancer;FunDO |
Disease | Heart disease;FunDO |
Disease | alcohol liver disease;GAD |
Disease | myocardial infarct;GAD |
Disease | alcohol abuse cirrhosis, alcoholic pancreatitis, chronic;GAD |
Disease | Atherosclerosis;FunDO |
Sequence Information | |
|---|---|
Nucleotide Sequence | >217 : length: 2076 ATTGGCTGCCGCGCGGGGCGGGGAGCGGGGTCGGCTCAGTGGCCCTGAGACCCTAGCTCTGCTCTCGGTCCGCTCGCTGTCCGCTAGCCCGCTGCGATGTTGCGCGCTGCCGCCCGCTTC GGGCCCCGCCTGGGCCGCCGCCTCTTGTCAGCCGCCGCCACCCAGGCCGTGCCTGCCCCCAACCAGCAGCCCGAGGTCTTCTGCAACCAGATTTTCATAAACAATGAATGGCACGATGCC GTCAGCAGGAAAACATTCCCCACCGTCAATCCGTCCACTGGAGAGGTCATCTGTCAGGTAGCTGAAGGGGACAAGGAAGATGTGGACAAGGCAGTGAAGGCCGCCCGGGCCGCCTTCCAG CTGGGCTCACCTTGGCGCCGCATGGACGCATCACACAGGGGCCGGCTGCTGAACCGCCTGGCCGATCTGATCGAGCGGGACCGGACCTACCTGGCGGCCTTGGAGACCCTGGACAATGGC AAGCCCTATGTCATCTCCTACCTGGTGGATTTGGACATGGTCCTCAAATGTCTCCGGTATTATGCCGGCTGGGCTGATAAGTACCACGGGAAAACCATCCCCATTGACGGAGACTTCTTC AGCTACACACGCCATGAACCTGTGGGGGTGTGCGGGCAGATCATTCCGTGGAATTTCCCGCTCCTGATGCAAGCATGGAAGCTGGGCCCAGCCTTGGCAACTGGAAACGTGGTTGTGATG AAGGTAGCTGAGCAGACACCCCTCACCGCCCTCTATGTGGCCAACCTGATCAAGGAGGCTGGCTTTCCCCCTGGTGTGGTCAACATTGTGCCTGGATTTGGCCCCACGGCTGGGGCCGCC ATTGCCTCCCATGAGGATGTGGACAAAGTGGCATTCACAGGCTCCACTGAGATTGGCCGCGTAATCCAGGTTGCTGCTGGGAGCAGCAACCTCAAGAGAGTGACCTTGGAGCTGGGGGGG AAGAGCCCCAACATCATCATGTCAGATGCCGATATGGATTGGGCCGTGGAACAGGCCCACTTCGCCCTGTTCTTCAACCAGGGCCAGTGCTGCTGTGCCGGCTCCCGGACCTTCGTGCAG GAGGACATCTATGATGAGTTTGTGGAGCGGAGCGTTGCCCGGGCCAAGTCTCGGGTGGTCGGGAACCCCTTTGATAGCAAGACCGAGCAGGGGCCGCAGGTGGATGAAACTCAGTTTAAG AAGATCCTCGGCTACATCAACACGGGGAAGCAAGAGGGGGCGAAGCTGCTGTGTGGTGGGGGCATTGCTGCTGACCGTGGTTACTTCATCCAGCCCACTGTGTTTGGAGATGTGCAGGAT GGCATGACCATCGCCAAGGAGGAGATCTTCGGGCCAGTGATGCAGATCCTGAAGTTCAAGACCATAGAGGAGGTTGTTGGGAGAGCCAACAATTCCACGTACGGGCTGGCCGCAGCTGTC TTCACAAAGGATTTGGACAAGGCCAATTACCTGTCCCAGGCCCTCCAGGCGGGCACTGTGTGGGTCAACTGCTATGATGTGTTTGGAGCCCAGTCACCCTTTGGTGGCTACAAGATGTCG GGGAGTGGCCGGGAGTTGGGCGAGTACGGGCTGCAGGCATACACTGAAGTGAAAACTGTCACAGTCAAAGTGCCTCAGAAGAACTCATAAGAATCATGCAAGCTTCCTCCCTCAGCCATT GATGGAAAGTTCAGCAAGATCAGCAACAAAACCAAGAAAAATGATCCTTGCGTGCTGAATATCTGAAAAGAGAAATTTTTCCTACAAAATCTCTTGGGTCAAGAAAGTTCTAGAATTTGA ATTGATAAACATGGTGGGTTGGCTGAGGGTAAGAGTATATGAGGAACCTTTTAAACGACAACAATACTGCTAGCTTTCAGGATGATTTTTAAAAAATAGATTCAAATGTGTTATCCTCTC TCTGAAACGCTTCCTATAACTCGAGTTTATAGGGGAAGAAAAAGCTATTGTTTACAATTATATCACCATTAAGGCAACTGCTACACCCTGCTTTGTATTCTGGGCTAAGATTCATTAAAA ACTAGCTGCTCTTAACTTACAAAAAAAAAAAAAAAA |
Protein Sequence | >217 : length: 517 MLRAAARFGPRLGRRLLSAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLA ALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPG FGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGP QVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQS PFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS |